Lipella Pharmaceuticals is a clinical-stage biotechnology company focused on reformulating active agents from existing generic drugs for new applications. Its pipeline includes LP-10 (tacrolimus for hemorrhagic cystitis), LP-310 (tacrolimus for oral lichen planus), LP-410 (tacrolimus for oral graft-versus-host disease), and LP-50 (intravesical immunoglobulins for non-muscle invasive bladder cancer). The company uses a proprietary metastable liposome drug delivery platform to optimize local delivery to body cavities, pursuing orphan drug designations and the 505(b)(2) regulatory pathway.
Q2 FY2026 — expected 2026-09-17
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-03-28 | 2024-12-31 | 0001753926-25-000507 | EDGAR | 79K words |
| 2024-02-27 | 2023-12-31 | 0001753926-24-000403 | EDGAR | 71K words |
| 2023-03-31 | 2022-12-31 | 0001753926-23-000352 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-14 | 2025-09-30 | 0001753926-25-001805 | EDGAR | 23K words |
| 2025-08-14 | 2025-06-30 | 0001753926-25-001347 | EDGAR | 23K words |
| 2025-05-14 | 2025-03-31 | 0001753926-25-000818 | EDGAR | 21K words |
| 2024-11-14 | 2024-09-30 | 0001753926-24-001927 | EDGAR | 19K words |
| 2024-08-13 | 2024-06-30 | 0001753926-24-001419 | EDGAR | 18K words |
| 2024-05-09 | 2024-03-31 | 0001753926-24-000943 | EDGAR | 17K words |
| 2023-11-14 | 2023-09-30 | 0001753926-23-001484 | EDGAR | 20K words |
| 2023-08-14 | 2023-06-30 | 0001753926-23-001052 | EDGAR | 20K words |
| 2023-05-12 | 2023-03-31 | 0001753926-23-000649 | EDGAR | 18K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-07-15 | 0001753926-26-001173 | EDGAR | 15K words |
| 2026-03-31 | 0001753926-26-000577 | EDGAR | 1K words |
| 2026-02-04 | 0001753926-26-000265 | EDGAR | 0K words |
| 2025-10-21 | 0001753926-25-001636 | EDGAR | 0K words |
| 2025-10-09 | 0001753926-25-001602 | EDGAR | 0K words |
| 2025-09-18 | 0001753926-25-001525 | EDGAR | 4K words |
| 2025-06-25 | 0001753926-25-001003 | EDGAR | 1K words |
| 2025-06-20 | 0001753926-25-000984 | EDGAR | 1K words |
| 2025-06-16 | 0001753926-25-000962 | EDGAR | 1K words |
| 2025-05-16 | 0001753926-25-000856 | EDGAR | 1K words |
77 total filings indexed. 55 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001347242 |
| Ticker | LIPO |
| Exchange | OTC |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/LIPO (~200 tokens, structured JSON with cryptographic provenance)